Two Sigma Investments, LP 89bio, Inc. Transaction History

Two Sigma Investments, LP

$42.3 Billion
Q3 2024

A detailed history of Two Sigma Investments, LP transactions in 89bio, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 368,688 shares of ETNB stock, worth $3.57 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

368,688

Previous 533,717 30.92%

Holding current value

$3.57 Million

Previous $4.28 Million 36.19%

% of portfolio

0.01%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$7.36 - $9.66 $1.21 Million - $1.59 Million	-165,029 Reduced 30.92%	368,688 $2.73 Million
Q2 2024 Aug 14, 2024	BUY	$7.31 - $10.9 $2.1 Million - $3.14 Million	287,617 Added 116.87%	533,717 $4.28 Million
Q1 2024 May 15, 2024	BUY	$8.13 - $13.77 $953,990 - $1.62 Million	117,342 Added 91.13%	246,100 $2.86 Million
Q4 2023 Feb 14, 2024	SELL	$6.66 - $16.03 $552,906 - $1.33 Million	-83,019 Reduced 39.2%	128,758 $1.44 Million
Q3 2023 Nov 14, 2023	SELL	$15.06 - $19.41 $6.34 Million - $8.17 Million	-420,908 Reduced 66.53%	211,777 $3.27 Million
Q2 2023 Aug 14, 2023	SELL	$14.15 - $22.03 $3.33 Million - $5.18 Million	-235,276 Reduced 27.11%	632,685 $12 Million
Q1 2023 May 15, 2023	BUY	$10.48 - $16.94 $1.61 Million - $2.61 Million	153,796 Added 21.54%	867,961 $13.2 Million
Q4 2022 Feb 14, 2023	BUY	$5.52 - $12.73 $1.24 Million - $2.86 Million	224,641 Added 45.89%	714,165 $9.09 Million
Q3 2022 Nov 14, 2022	BUY	$3.02 - $7.0 $1 Million - $2.33 Million	332,610 Added 211.97%	489,524 $2.83 Million
Q2 2022 Aug 15, 2022	SELL	$2.09 - $4.02 $132,723 - $255,286	-63,504 Reduced 28.81%	156,914 $505,000
Q1 2022 May 16, 2022	BUY	$3.45 - $14.99 $561,532 - $2.44 Million	162,763 Added 282.31%	220,418 $831,000
Q4 2021 Feb 14, 2022	SELL	$11.15 - $19.66 $216,321 - $381,423	-19,401 Reduced 25.18%	57,655 $754,000
Q3 2021 Nov 15, 2021	SELL	$14.91 - $21.31 $361,224 - $516,277	-24,227 Reduced 23.92%	77,056 $1.51 Million
Q2 2021 Aug 16, 2021	SELL	$17.42 - $28.0 $991,076 - $1.59 Million	-56,893 Reduced 35.97%	101,283 $1.89 Million
Q1 2021 May 17, 2021	SELL	$20.22 - $26.73 $206,345 - $272,779	-10,205 Reduced 6.06%	158,176 $3.75 Million
Q4 2020 Feb 16, 2021	BUY	$23.16 - $28.08 $2.59 Million - $3.14 Million	111,821 Added 197.7%	168,381 $4.1 Million
Q3 2020 Nov 16, 2020	BUY	$24.34 - $38.82 $1.38 Million - $2.2 Million	56,560 New	56,560 $1.45 Million

Others Institutions Holding ETNB

# of Institutions

163

Shares Held

108M

Call Options Held

73.6K

Put Options Held

1.19M

View Full List

About 89bio, Inc.

Ticker ETNB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,484,500
Market Cap $450M
Description
89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...

More about ETNB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP 89bio, Inc. Transaction History